These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 6109615)

  • 21. Ovine fetal-placental cocaine pharmacokinetics during continuous cocaine infusion.
    Downs T; Padbury J; Blount L; Kashiwai K; Chan K
    J Soc Gynecol Investig; 1996; 3(4):185-90. PubMed ID: 8796829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine.
    Yoon EJ; Lee WI; Shim HJ; Lee SD; Kim WB; Yang J; Lee MG
    Biopharm Drug Dispos; 1996 Jul; 17(5):373-420. PubMed ID: 8830976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy-associated hypercalcemia.
    Usui T; Oiso Y; Tomita A; Ogata E; Uchida T; Ikeda K; Watanabe T; Higuchi S
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):239-44. PubMed ID: 9208339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of cladribine (2-chlorodeoxyadenosine) in children with acute leukemia.
    Kearns CM; Blakley RL; Santana VM; Crom WR
    Cancer Res; 1994 Mar; 54(5):1235-9. PubMed ID: 7906999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical pharmacokinetics of vinorelbine (Navelbine).
    Wargin WA; Lucas VS
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):21-7. PubMed ID: 7973765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I pharmacokinetic study of cyclosporin A combined with doxorubicin.
    Erlichman C; Moore M; Thiessen JJ; Kerr IG; Walker S; Goodman P; Bjarnason G; DeAngelis C; Bunting P
    Cancer Res; 1993 Oct; 53(20):4837-42. PubMed ID: 8402670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of aztreonam administered by continuous intravenous infusion.
    Burgess DS; Summers KK; Hardin TC
    Clin Ther; 1999 Nov; 21(11):1882-9. PubMed ID: 10890260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-independent pharmacokinetics of the cardioprotective agent dexrazoxane in dogs.
    Baldwin JR; Lewis RC; Phillips BA; Overmyer SK; Hatfield NZ; Narang PK
    Biopharm Drug Dispos; 1996 Aug; 17(6):541-50. PubMed ID: 8866044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacokinetics of vinblastine by continuous intravenous infusion.
    Lu K; Yap HY; Loo TL
    Cancer Res; 1983 Mar; 43(3):1405-8. PubMed ID: 6825110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and pharmacodynamics of BIBT 986, a novel small molecule dual inhibitor of thrombin and factor Xa.
    Graefe-Mody EU; Schühly U; Rathgen K; Stähle H; Leitner JM; Jilma B
    J Thromb Haemost; 2006 Jul; 4(7):1502-9. PubMed ID: 16839346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of infusion rate on thiopental dose-response relationships. Assessment of a pharmacokinetic-pharmacodynamic model.
    Gentry WB; Krejcie TC; Henthorn TK; Shanks CA; Howard KA; Gupta DK; Avram MJ
    Anesthesiology; 1994 Aug; 81(2):316-24; discussion 25A. PubMed ID: 8053580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial experience with Minaxolone. A water-soluble steroid intravenous anaesthetic agent.
    Punchihewa VG; Morgan M; Lumley J; Whitwam JG
    Anaesthesia; 1980 Feb; 35(2):214-7. PubMed ID: 7386840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of G3139, a phosphorothioate oligodeoxynucleotide antisense to bcl-2, after intravenous administration or continuous subcutaneous infusion to mice.
    Raynaud FI; Orr RM; Goddard PM; Lacey HA; Lancashire H; Judson IR; Beck T; Bryan B; Cotter FE
    J Pharmacol Exp Ther; 1997 Apr; 281(1):420-7. PubMed ID: 9103525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extrahepatic extraction of salicylamide in dogs.
    Fielding RM; Waschek JA; Effeney DJ; Pogany AC; Pond SM; Tozer TN
    J Pharmacol Exp Ther; 1986 Jan; 236(1):97-102. PubMed ID: 3941404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minaxolone: an evaluation with and without premedication.
    McNeill HG; Clarke RS; Dundee JW; Briggs LP
    Anaesthesia; 1981 Jun; 36(6):592-6. PubMed ID: 7270828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An early clinical assessment of the steroid anaesthetic Minaxolone.
    Dunn GL; Morison DH; McChesney J; Pine W
    Can Anaesth Soc J; 1980 Mar; 27(2):140-5. PubMed ID: 7363142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of contrast media in humans: model with circulation, distribution, and renal excretion.
    Lawaczeck R; Jost G; Pietsch H
    Invest Radiol; 2011 Sep; 46(9):576-85. PubMed ID: 21654496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Respiratory effects of Minaxolone.
    Puchihewa VG; Whitwam JG; Morgan M; Lumley J
    Anaesthesia; 1980 Jun; 35(6):611-3. PubMed ID: 7435925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biliary excretion and enterohepatic circulation of pregnanolone in the rat.
    Long RJ; Soyka LF
    Biochem Pharmacol; 1975 May; 24(10):1067-72. PubMed ID: 1156432
    [No Abstract]   [Full Text] [Related]  

  • 40. Minaxolone and malignant hyperthermia.
    Harrison GG; Morrell DF
    Br J Anaesth; 1980 Jul; 52(7):706-7. PubMed ID: 7426245
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.